Cargando…
Formulation and evaluation of an in situ gel-forming ophthalmic formulation of moxifloxacin hydrochloride
BACKGROUND/AIM: The aim of the present investigation is to prepare and evaluate in situ gel-forming ophthalmic drug delivery system of moxifloxacin hydrochloride. MATERIALS AND METHODS: Sodium alginate, a novel ophthalmic gel-forming mucoadhesive polymer, which gets converted to gel in the presence...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3482769/ https://www.ncbi.nlm.nih.gov/pubmed/23119236 http://dx.doi.org/10.4103/2230-973X.100042 |
_version_ | 1782247907299164160 |
---|---|
author | Mandal, Sonjoy Thimmasetty, Manjunath KMJ Prabhushankar, GL Geetha, MS |
author_facet | Mandal, Sonjoy Thimmasetty, Manjunath KMJ Prabhushankar, GL Geetha, MS |
author_sort | Mandal, Sonjoy |
collection | PubMed |
description | BACKGROUND/AIM: The aim of the present investigation is to prepare and evaluate in situ gel-forming ophthalmic drug delivery system of moxifloxacin hydrochloride. MATERIALS AND METHODS: Sodium alginate, a novel ophthalmic gel-forming mucoadhesive polymer, which gets converted to gel in the presence of divalent-cations (calcium ion) present in the lachrymal fluid, was used as the gelling agent. Hydroxy propyl methyl cellulose (HPMC) is a mucoadhesive polymer used as viscosity enhancer. Suitable concentrations of buffering agents were used to adjust the pH to 6.5. All the formulations were sterilized in an autoclave at 121°C for 15 minutes. The formulations were evaluated for clarity, pH measurement, gelling capacity, drug content estimation, rheological study, in vitro diffusion study, antibacterial activity, isotonicity, and eye irritation study. RESULTS: The developed formulations exhibited sustained release of drug from formulation over a period of 10 hours thus increasing residence time of the drug. The optimized formulations were tested for eye irritation on albino rabbit (male). The formulations were found to be non-irritating with no ocular damage or abnormal clinical signs to the cornea, iris or conjunctiva observed. CONCLUSION: These in situ gelling systems containing gums may be a valuable alternative to the conventional systems. |
format | Online Article Text |
id | pubmed-3482769 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-34827692012-11-01 Formulation and evaluation of an in situ gel-forming ophthalmic formulation of moxifloxacin hydrochloride Mandal, Sonjoy Thimmasetty, Manjunath KMJ Prabhushankar, GL Geetha, MS Int J Pharm Investig Original Research Article BACKGROUND/AIM: The aim of the present investigation is to prepare and evaluate in situ gel-forming ophthalmic drug delivery system of moxifloxacin hydrochloride. MATERIALS AND METHODS: Sodium alginate, a novel ophthalmic gel-forming mucoadhesive polymer, which gets converted to gel in the presence of divalent-cations (calcium ion) present in the lachrymal fluid, was used as the gelling agent. Hydroxy propyl methyl cellulose (HPMC) is a mucoadhesive polymer used as viscosity enhancer. Suitable concentrations of buffering agents were used to adjust the pH to 6.5. All the formulations were sterilized in an autoclave at 121°C for 15 minutes. The formulations were evaluated for clarity, pH measurement, gelling capacity, drug content estimation, rheological study, in vitro diffusion study, antibacterial activity, isotonicity, and eye irritation study. RESULTS: The developed formulations exhibited sustained release of drug from formulation over a period of 10 hours thus increasing residence time of the drug. The optimized formulations were tested for eye irritation on albino rabbit (male). The formulations were found to be non-irritating with no ocular damage or abnormal clinical signs to the cornea, iris or conjunctiva observed. CONCLUSION: These in situ gelling systems containing gums may be a valuable alternative to the conventional systems. Medknow Publications & Media Pvt Ltd 2012 /pmc/articles/PMC3482769/ /pubmed/23119236 http://dx.doi.org/10.4103/2230-973X.100042 Text en Copyright: © International Journal of Pharmaceutical Investigation http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Research Article Mandal, Sonjoy Thimmasetty, Manjunath KMJ Prabhushankar, GL Geetha, MS Formulation and evaluation of an in situ gel-forming ophthalmic formulation of moxifloxacin hydrochloride |
title | Formulation and evaluation of an in situ gel-forming ophthalmic formulation of moxifloxacin hydrochloride |
title_full | Formulation and evaluation of an in situ gel-forming ophthalmic formulation of moxifloxacin hydrochloride |
title_fullStr | Formulation and evaluation of an in situ gel-forming ophthalmic formulation of moxifloxacin hydrochloride |
title_full_unstemmed | Formulation and evaluation of an in situ gel-forming ophthalmic formulation of moxifloxacin hydrochloride |
title_short | Formulation and evaluation of an in situ gel-forming ophthalmic formulation of moxifloxacin hydrochloride |
title_sort | formulation and evaluation of an in situ gel-forming ophthalmic formulation of moxifloxacin hydrochloride |
topic | Original Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3482769/ https://www.ncbi.nlm.nih.gov/pubmed/23119236 http://dx.doi.org/10.4103/2230-973X.100042 |
work_keys_str_mv | AT mandalsonjoy formulationandevaluationofaninsitugelformingophthalmicformulationofmoxifloxacinhydrochloride AT thimmasettymanjunathkmj formulationandevaluationofaninsitugelformingophthalmicformulationofmoxifloxacinhydrochloride AT prabhushankargl formulationandevaluationofaninsitugelformingophthalmicformulationofmoxifloxacinhydrochloride AT geethams formulationandevaluationofaninsitugelformingophthalmicformulationofmoxifloxacinhydrochloride |